Evaluation of Naturally Occurring HIF‐1 Inhibitors for Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Evaluation of Naturally Occurring HIF‐1 Inhibitors for Pulmonary Arterial Hypertension

Published:2021-07-09 Issue:18 Volume:22 Page:2799-2804
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Arai Midori A.¹^ORCID,Sakuraba Kota²,Makita Yoshinori¹²,Hara Yasumasa²,Ishibashi Masami²

Affiliation:

1. Department of Biosciences and Informatics Faculty of Science and Technology Keio University 3-14-1 Hiyoshi, Kohoku-ku Yokohama Kanagawa 223-8522 Japan

2. Graduate School of Pharmaceutical Sciences Chiba University 1-8-1 Inohana, Chuo-ku Chiba 260-8675 Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.202100223

Reference28 articles.

2. The Cancer Paradigm of Severe Pulmonary Arterial Hypertension

3. Pulmonary Hypertension and Right Heart Failure in Chronic Obstructive Pulmonary Disease

4. Pulmonary hypertension in interstitial lung disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salidroside enhances NO bioavailability and modulates arginine metabolism to alleviate pulmonary arterial hypertension;European Journal of Medical Research;2024-08-17

2. Physalin H, physalin B, and isophysalin B suppress the quorum-sensing function of Staphylococcus aureus by binding to AgrA;Frontiers in Pharmacology;2024-04-10

3. Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats;International Heart Journal;2024-03-30

4. Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment;International Journal of Medical Sciences;2024

5. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets;Signal Transduction and Targeted Therapy;2023-11-20